Humanware, a spin-off of the Scuola Superiore Sant'Anna in Pisa, is composed of researchers and engineers with many years of experience in the field of robotics, mechatronics and virtual reality.
Humanware proposes new solutions and technologies in the field of medicine and in particular rehabilitation to facilitate the recovery of patients and assist the work of clinicians.
The core-business is realized in the development of new robotic interfaces for neuro-motor and cognitive rehabilitation able to allow a decisive step forward towards a more intense and fun rehabilitation for patients and more advantageous and comfortable for therapists.
The company also operates successfully in the information technology market with constant growth thanks to continuous investments in know-how and the seriousness and efficiency with which it supports its customers.
Humanware also operates in the field of engineering services and R&D, offering customers excellent solutions to their needs in different scientific and technological domains.
I4.0 Group was founded in October 2017. The two founding partners have complementary professional backgrounds. A combination of experiences gained in the most important pharmaceutical players worldwide and dozens of projects successfully implemented for the most important players in the Italian manufacturing, energy and transport industries. The objective of I4.0 Group is to become a strategic partner for the customer in helping and guiding him through the challenges of the fourth industrial revolution, thanks to the years of experience of the team on DCS, SCADA, PLC, MES, Data Historian, 3D Modelling systems made in large industrial contexts in the manufacturing processes of the pharmaceutical, chemical, energy, transport and oil & gas. I4.0 Group can also support the customer throughout the process to benefit from tax instruments dedicated to I4.0.
GMP production of radiopharmaceuticals (cyclotron available) for medical-nuclear diagnostics and clinical research. Under activation the service of campaign and sample production for the development of new radiopharmaceuticals (new molecules and biotechnological products, behind registration dossiers or IMPDs) with potential clinical application. Design, development and validation of radiopharmaceutical production processes for human use for diagnosis and clinical research purposes, also supporting the development of conventional and biotechnological drugs. Non-clinical preparation, testing and experimentation of new radiopharmaceuticals.
Ospedale del Cuore Via Aurelia Sud - 54100 - Massa
The Biomaterials Laboratory of the Institute of Clinical Physiology of the CNR (IFC-CNR) deals with the development and characterization of polymeric biomaterials and biomedical devices, mainly for cardiovascular applications. The devices are manufactured using spray technology based on phase inversion by Advanced spray-machines in clean room class 100. The devices are characterized by evaluation of biocompatibility in vitro (through cell cultures and vitality and proliferation assays) and in vivo (through subcutaneous implantation in small animals and histological analysis), haemocompatibility (platelet and coagulation system activation), chemical properties (infrared analysis FT-IR/ATR) and mechanical properties (uniaxial tensile test and fatigue tests).
The studies are carried out in the framework of national and international projects and collaborations with research institutions and leading companies in the biomedical sector.
Particular importance is given to small diameter vascular prostheses, patches for skin application and heart valves, such as a patented one-body polymer heart valve, which has entered the animal testing phase.
Imaginalis, a company of the Epica International group, was founded in 2013 as a result of a project co-financed by the Tuscany Region, lead by El.En. S.p.A., in the opto-mechatronics cluster . The result of the project was the development of an innovative Tac 3D imaging technology at high spatial resolution for stratigraphic analysis. This technology has been applied to the veterinary field, developing automated and robotic Tac for small and large animals with three-dimensional technology, developing software to compensate for the movement of animals. The versatility of the solutions identified allows their application also in the productive sectors, for example in the manufacturing of leather and food, thanks to the non-destructive tests associated with the very high resolution scans. Imaginalis is developing imaging and robotic surgery applications driven by both veterinary and human 3D images.
Via del Parlamento Europeo, 9/D - 50018 - Scandicci-FI
ITALRAY Srl, founded in 1974, has its headquarters and production activities in Scandicci (FI), and operates in the field of diagnostic imaging with a particular focus and experience in digital X-ray imaging. ITALRAY follows all phases of the product, from research and development, to production, marketing, installation and
technical assistance. ITALRAY's Research and Development department constantly follows the latest generation technologies, creating advanced products, extremely reliable and characterized by a total cost of ownership absolutely competitive. ITALRAY offers its customers, both Italian and foreign, a complete range of X-ray solutions ranging from simple portable units to complete DR (Digital Radiology) rooms.
The cluster network provides a large panel of services and products for the growth of life sciences in Tuscany.
Here you can find an updated list of the facilties and equipments that the Cluster network makes available for the development of business projects and research activities.
The updated map with all members of the Cluster. Here you can find contacts of companies, research groups and organisations connected to the Tuscany cluster.